| 000 | 01588 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518002013.0 | ||
| 264 | 0 | _c20190606 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1468-3083 | ||
| 024 | 7 |
_a10.1111/jdv.15277 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSawyer, L M | |
| 245 | 0 | 0 |
_aLong-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response. _h[electronic resource] |
| 260 |
_bJournal of the European Academy of Dermatology and Venereology : JEADV _cFeb 2019 |
||
| 300 |
_a355-366 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Systematic Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aBiological Products _xadministration & dosage |
| 650 | 0 | 4 |
_aDermatologic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNetwork Meta-Analysis |
| 650 | 0 | 4 | _aPatient Safety |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aCornic, L | |
| 700 | 1 | _aLevin, L Å | |
| 700 | 1 | _aGibbons, C | |
| 700 | 1 | _aMøller, A H | |
| 700 | 1 | _aJemec, G B | |
| 773 | 0 |
_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 33 _gno. 2 _gp. 355-366 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jdv.15277 _zAvailable from publisher's website |
| 999 |
_c28907747 _d28907747 |
||